Report on Deep Vein Thrombosis (DVT) Study: Methodology and Findings
VerifiedAdded on  2020/10/22
|4
|555
|97
Report
AI Summary
This report presents a study focusing on Deep Vein Thrombosis (DVT), comparing a new anticoagulant drug with Warfarin. The study employs an interventional design, examining 100 patients with DVT, considering factors such as obesity, paralysis, and surgery. The primary outcome measure is the observation of patients with DVT. The report details the population source, selection bias considerations, and confounding factors, including the potential for misclassification due to measurement errors. References include articles on DVT, cohort study designs, and postoperative venous thromboembolism. The methodology includes a parallel design and addresses potential biases such as those related to specific symptoms and the exclusion of factors like age and gender. The study aims to assess the efficacy of the new drug, considering potential sources of error and confounding variables, with the goal of improving DVT treatment.
1 out of 4